Evaluation of serum lipids and carotid artery intima media thickness in epileptic children treated with valproic acid

Brain and Development

Volumn 31, Issue 10, 2009, Pages 713-716

  Erdemir, Aydin ^a   Çullu, Neşat ^a   Yiş, Uluç ^a   Demircioǧlu, Fatih ^a   Kir, Mustafa ^a   Çakmakçi, Handan ^a   Ünal, Nurettin ^a   Dirik, Eray ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Child; Epilepsy; Intima media thickness; Valproic acid

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VALPROIC ACID;

ADOLESCENT; ADULT; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; BRAIN ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EPILEPSY; FEMALE; HUMAN; MALE; SCHOOL CHILD; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ATHEROSCLEROSIS; CAROTID ARTERY, COMMON; CAROTID STENOSIS; CHILD; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; MALE; RISK FACTORS; TRIGLYCERIDES; TUNICA INTIMA; TUNICA MEDIA; VALPROIC ACID;

EID: 70350169250     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2008.11.001     Document Type: Article

References (24)

1. Forsgren L. Incidence and prevalence. In: Wallace S.J., and Farrell K. (Eds). Epilepsy in children. 2nd ed. (2004), Arnold, London 21-25
2. Wallace S.J. A comparative review of the adverse effects of anticonvulsant in children with epilepsy. Drug Saf 15 (1996) 378-393
3. Calandre E.P., Rodríguez-López C., Blazquez A., and Cano D. Serum lipids, lipoprotein and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital. Acta Neurol Scand 83 (1991) 250-253
4. Franzoni E., Govoni M., D'Addato S., et al. Total cholesterol, high-density lipoprotein cholesterol and triglycerides in children receiving antiepileptic drugs. Epilepsia 33 (1992) 932-935
5. Zeitlhofer J., Doppelbauer A., Tribl G., et al. Changes of serum lipid patterns during long-term anticonvulsive treatment. Clin Invest 71 (1993) 574-578
6. Yalçin E., Hassanzadeh A., and Mawlud K. The effects of long-term anticonvulsive treatment on serum lipid profile. Acta Paediatr Jpn 39 (1997) 342-345
7. Demircioglu S., Soylu A., and Dirik E. Carbamazepine and valproic acid: Effects on the serum lipids and liver functions in children. Pediatr Neurol 23 (2000) 142-146
8. Sönmez F.M., Demir E., Orem A., et al. Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes. J Child Neurol 21 (2006) 70-74
9. Annegers J.F., Hauser W.A., and Shirts S.B. Heart disease mortality and morbidity in patients with epilepsy. Epilepsia 25 (1984) 699-704
10. Friedewald W.T., Levy R., and Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
11. Nicholson J.F., and Pesce M.A. Reference ranges for laboratory tests and procedures. In: Behrman R.E., and Kliegman R.M. (Eds). Nelson textbook of pediatrics (2004), Elsevier Science, Philadelphia 2396-2427
12. Havel R. Genetic underpinnings of LDL size and density: a role for hepatic lipase. Amer J Clin Nutr 71 (2000) 1390-1391
13. Eirís J.M., Lojo S., Del Río M.C., et al. Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy. Neurology 45 (1995) 1155-1157
14. Heldemberg D., Harel S., Holtzman M., et al. The effect of chronic anticonvulsant therapy on serum lipids and lipoproteins in epileptic children. Neurology 33 (1983) 510-513
15. Kürekci A.E., Alpay F., Tanindi S., et al. Plasma trace elements, plasma glutathione peroxidase levels in epileptic children, receiving antiepileptic drug therapy. Epilepsia 36 (1995) 600-604
16. Aynaci F.M., Orhan F., Orem A., Yildirmis S., and Gedik Y. Effect of antiepileptic drugs on plasma lipoprotein (a) and other lipid levels in childhood. J Child Neur 16 (2001) 367-369
17. Verrotti A., Basciani F., Domizio S., et al. Serum lipids and lipoproteins in patients treated with antiepileptic drugs. Pediatr Neurol 19 (1998) 364-367
18. Samed H.A., Hamed E.A., Hamdy R., and Nabeshima T. Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy. Epilepsy Res 74 (2007) 183-192
19. Schwaninger M., Ringleb P., Annecke A., et al. Elevated plasma concentrations of lipoprotein (a) in medicated epileptic patients. J Neurol 247 (2000) 687-690
20. Dahlen G.H. Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 108 (1994) 111-126
21. Isojarvi J.I., Laatikainen T.J., Knip M., et al. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 39 (1996) 579-584
22. Pippenger C.E., Meng X., Von Lente F., et al. Valproate therapy depresses GSH-Px and superoxide dismutase enzyme activity. A possible mechanism for VPA induced idiosyncratic drug toxicity. Clin Chem 35 (1989) 1173
23. Cotario D., Evans S., Zaidman J.L., et al. Early changes in hepatic redox homeostasis following treatment with a single dose of valproic acid. Biochem Pharmacol 40 (1990) 589-593
24. Yüksel A., Cengiz M., Seven M., and Ulutin T. Changes in the antioxidant system in epileptic children receiving antiepileptic drugs: two year prospective studies. J Child Neurol 16 (2001) 603-606